Read more on the Financial Times Article; UK brain monitoring start-up goes from teenage idea to $100mn funding.

We are delighted to confirm we have secured $102.5 million in funding. Our latest round was led by Plural with participation from existing investors Angelini Ventures, LocalGlobe, Octopus Ventures, Crane, Backed VC and Entrepreneurs First to advance regulatory approval of our first product, CoMind One, as well as support completion of additional clinical trials, team expansion, and manufacturing partnerships.

For decades, doctors treating critically ill patients have been forced to compromise when monitoring the brain: use risky, expensive, highly invasive procedures that require drilling a hole into a patient's skull, or rely on inaccurate non-invasive monitoring that can compromise treatment decisions. CoMind's technology resolves this dilemma for the first time.

CoMind One is designed to make critical information about cerebral blood flow, cerebral autoregulation, and intracranial pressure easily and continually available at the bed-side for the first time, allowing clinicians to make life-saving decisions.

We're excited to advance our mission of redefining the way the brain is measured and treated.